Search

everythinglearnresearchcommunity

for

Search:↓

A user is seeking advice on where to buy 6% Minoxidil in the US without continuing with Curology. They are currently using a mixture of 6% Minoxidil, 2% Ketoconazole, and 2% Caffeine but have not seen results yet.

The conversation is about people with advanced hair loss (Norwood 6 or 7) who have seen significant hair regrowth using treatments like finasteride, minoxidil, microneedling, and RU58841. Nine cases were collected to motivate others to try these treatments despite advanced hair loss.

PTD-DBM is being explored for hair regrowth by targeting CXXC5, with clinical trials expected after pre-clinical studies. Users express anticipation and skepticism about its effectiveness.

User shared 6-month hair loss treatment update with Dut 3x/week, oral min, and dut+prp mesotherapy. Experienced positive results, no side effects, and recommends the regimen.

KX-826 is discussed as a hair loss treatment, with comparisons to finasteride. It is noted to be more expensive, harder to source, and generally used for stabilization rather than growth.

The user shared progress pictures after using finasteride and minoxidil for 6 months, expressing increased confidence. One user suggested using glasses with stronger prescription.

The user completed 6 months of using topical liquid minoxidil and oral finasteride, experiencing initial hair shedding followed by gradual regrowth after 2 months. They also dealt with dandruff and reported no negative impact on sex drive.

Emerging hair loss treatments like PP405, a topical MPC inhibitor, show promise in activating stem cells for hair growth. The conversation seeks information on the development stages and accessibility of these treatments.

A user shared their positive experience with a hair transplant in Turkey, where they received 3500 grafts. They started using finasteride, minoxidil, biotin, and ajuga reptans supplements after one month, and posted progress pictures at 1, 2, and 6 months post-transplant.

A 24-year-old shares six months of hair loss treatment progress using oral finasteride, oral minoxidil, derma-stamping with topical minoxidil, and keto shampoo. The user is pleased with the results and plans to continue for another six months before considering a hair transplant.

The conversation is about the progress of clinical trials for SCUBE3, a potential hair loss treatment. Specific treatments mentioned include Minoxidil, finasteride, and RU58841.

The user humorously describes trying various hair loss treatments, including minoxidil, finasteride, and RU58841, with a satirical twist involving psychedelic experiences and imaginary entities. They mistakenly used LSD instead of RU58841 and plan to continue experimenting with other substances.

The conversation discusses a user's hair regrowth after two months using finasteride, minoxidil, derma rolling, biotin, and ketoconazole shampoo. Some users express skepticism, while others are impressed with the results.

Keratin microspheres may offer additional mechanisms to combat hair loss compared to minoxidil. The process to create these microspheres is relatively simple and can be done at home with basic equipment.

This conversation was about a user named Substantial_Pen_1099 who has been using an regimen of 5mg oral minoxidil, 1mg finasteride everyday, 2% keto shampoo every three days, and weekly 0.5mm dermarolling for hair loss treatment over the course of 3 months. Others in the conversation expressed disbelief at their progress, to which Substantial_Pen_1099 provided video proof as evidence.

The user has been using oral finasteride, topical minoxidil, a derma roller, and root activating shampoo for hair regrowth, seeing positive results without side effects. They apply minoxidil after using a 1.5mm derma roller and are considering switching to ketoconazole shampoo.

The user is using RU58841, Revivogen, Regenepure ketoconazole shampoo, and plans to use a stimufield cap to address hair loss. They aim to avoid finasteride and minoxidil while hoping to stop hair loss and regrow hair.

The conversation discusses the approval of Kintor Pharmaceutical's AR-PROTAC (GT20029) for clinical trials in China for acne and androgenic alopecia. One user expresses optimism about new treatments being developed and seeks clarification on how the new drug works, specifically if it temporarily degrades the AR protein to reduce DHT sensitivity in hair follicles.

A user shared their 6-month progress using 1mg finasteride, daily minoxidil, 1.5mm microneedling twice a week, biotin, and Nizoral shampoo, showing significant hair regrowth. Other users were impressed, noting the regrowth resembled a hair transplant.

A 28-year-old male shares progress on hair loss treatment using 0.5mg dutasteride and 5mg minoxidil, experiencing initial shedding but encouraged by community support. He also uses ketoconazole occasionally based on scalp oiliness.

The user shared progress on hair regrowth using a topical minoxidil/finasteride spray, dermarolling weekly, and a product similar to pp405. They reported some regrowth with no side effects from the new product.

The user is experiencing diffuse thinning and inflammation despite using 2.5mg dutasteride daily, ciclopirox, and ketoconazole shampoos. They are considering treatments like hydroxychloroquine and JAK inhibitors due to suspected scarring alopecia and have faced challenges in obtaining a scalp biopsy.

Scube3, a potential hair loss treatment, is unlikely to be released because it was given to a startup company, Amplifica, which may go bankrupt and fail to bring the treatment to market. Amplifica is prioritizing other treatments over Scube3, which could lead to financial loss and the end of Scube3's development.

The conclusion of the conversation is that the user "lemmeseesomeass" has experienced significant hair regrowth using a combination of RU58841, dutasteride, and minoxidil. They mention that RU58841 is effective but not medically approved. They provide instructions on how they use RU58841.

The user shared progress after six months using a topical mix of 0.3% finasteride and 6% minoxidil, reporting significant hair regrowth with minimal side effects. The product used is a spray from Hims, applied to the crown before bed.

FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

The user reported noticeable hair regrowth after using dutasteride 0.5 mg, oral minoxidil 2.5 mg daily, and ketoconazole shampoo weekly for six months. They are considering adding RU58841 for further improvement.

Significant hair regrowth was achieved over six months using minoxidil, finasteride, microneedling, biotin and collagen shampoo, and MSM powder. The user feels more confident and may consider a hair transplant if necessary.

The conversation discusses hair loss treatments, including topical and oral minoxidil, finasteride, RU58841, and microneedling. Users suggest adding oral dutasteride or finasteride for more effective results.

The user shared hair regrowth results after 6 months using finasteride, minoxidil, ketoconazole shampoo, and dermastamp, considering adding dutasteride or a hair transplant. They previously had a hair transplant and did not take medications initially, leading to further hair loss.